Randomized, double‐blind, phase 1a single‐ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers

W. Schmidt(Canadian Blood Services), Bruce D. Hammock(UC Davis Comprehensive Cancer Center), Cindy B. McReynolds(University of California, Davis), Karen Wagner(Agricultural Research Service), Jun Yang(UC Davis Comprehensive Cancer Center), Sung Hee Hwang(UC Davis Comprehensive Cancer Center), Glenn Croston, Thomas R. Hunt(Pharmaceutical Product Development (United States)), Theresa L. Pedersen(University of California, Davis), Irene Cortés‐Puch(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Theresa T. Pham(Pharmaceutical Product Development (United States))
Clinical and Translational Science
September 1, 2024
Cited by 19


Related Papers